NCT02120807 2023-01-26
Certolizumab in Combination With Chemotherapy for Patients With Stage IV Lung Adenocarcinomas
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
Memorial Sloan Kettering Cancer Center
Brigham and Women's Hospital
University of Erlangen-Nürnberg Medical School
University of Leeds
Arthritis Treatment Center, Maryland